The prevalence of PH was 12.8% in those hospitalized in 2018 with left heart disease, a lower percentage than found in previous research.

Jason Butler, an analyst from JMP Securities, reiterated the Buy rating on Cytokinetics (CYTK – Research Report). The associated price ...

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

Global Commercial Launch Preparations Underway for First Potential Approval Towards Building Specialty Cardiovascular Franchise Company Recently Launched Unbranded Disease Awareness Campaign “HCM ...

A new scientific statement issued today by the Heart Failure Society of America highlights a critical connection between heart failure (HF) and cancer, with shared mechanisms contributing to the ...

A new Scientific Statement published by the Heart Failure Society of America (HFSA) has revealed a critical connection ...

STAT asked 11 experts, including the FDA commissioner, why the world's wealthiest nation is doing so poorly on cardiovascular ...

Sexual dimorphism is identified in a mouse model of Friedreich’s ataxia, with males exhibiting a worse cardiac phenotype, low survival rate, as well as kidney and reproductive organ deficiencies.

USA: A recent study has emerged from the REBALANCE-HF randomized clinical trial, exploring the efficacy of endovascular ...

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

In patients with vs without history of incident heart failure hospitalization there is more rapid decline in global cognition.